Please upgrade your browser

We built this website using the latest browser technologies to deliver the very best experience.

This makes the site run faster and easier to use. Unfortunately, your browser is out of date and will not support some of these technologies.

We recommend that you use a modern browser such as Google Chrome or Microsoft Edge to view this website.

Download Microsoft EdgeDownload Microsoft Edge
Press release

Statement from Sensyne Health

October 27, 2020

It has been brought to the Company’s attention that our Annual Report, published on 6 October 2020, omitted to include the following statement:

“During the course of the financial year, Lorimer Headley left the Board. He was an instrumental part of the successful IPO of Sensyne Health plc and subsequent commercial agreements, and prior to that provided a valuable contribution to the development of Drayson Technologies. On behalf of the Board, we would like to thank Mr Headley for his significant contribution to Sensyne”.


The Board apologises to Mr Headley for the omission.

Press release

Statement from Sensyne Health

October 27, 2020

It has been brought to the Company’s attention that our Annual Report, published on 6 October 2020, omitted to include the following statement:

“During the course of the financial year, Lorimer Headley left the Board. He was an instrumental part of the successful IPO of Sensyne Health plc and subsequent commercial agreements, and prior to that provided a valuable contribution to the development of Drayson Technologies. On behalf of the Board, we would like to thank Mr Headley for his significant contribution to Sensyne”.


The Board apologises to Mr Headley for the omission.

Press release

Statement from Sensyne Health

Statement from Sensyne Health

October 27, 2020

It has been brought to the Company’s attention that our Annual Report, published on 6 October 2020, omitted to include the following statement:

“During the course of the financial year, Lorimer Headley left the Board. He was an instrumental part of the successful IPO of Sensyne Health plc and subsequent commercial agreements, and prior to that provided a valuable contribution to the development of Drayson Technologies. On behalf of the Board, we would like to thank Mr Headley for his significant contribution to Sensyne”.


The Board apologises to Mr Headley for the omission.

Press release

Statement from Sensyne Health

Statement from Sensyne Health

It has been brought to the Company’s attention that our Annual Report, published on 6 October 2020, omitted to include the following statement:

“During the course of the financial year, Lorimer Headley left the Board. He was an instrumental part of the successful IPO of Sensyne Health plc and subsequent commercial agreements, and prior to that provided a valuable contribution to the development of Drayson Technologies. On behalf of the Board, we would like to thank Mr Headley for his significant contribution to Sensyne”.


The Board apologises to Mr Headley for the omission.

Arrange to meet us
Press release

Statement from Sensyne Health

October 27, 2020

It has been brought to the Company’s attention that our Annual Report, published on 6 October 2020, omitted to include the following statement:

“During the course of the financial year, Lorimer Headley left the Board. He was an instrumental part of the successful IPO of Sensyne Health plc and subsequent commercial agreements, and prior to that provided a valuable contribution to the development of Drayson Technologies. On behalf of the Board, we would like to thank Mr Headley for his significant contribution to Sensyne”.


The Board apologises to Mr Headley for the omission.